-
281“…This review focuses on recent developments in the diagnosis, treatment, management, and strategies for the prevention and control of cutaneous leishmaniasis (CL) caused by both Old and New World Leishmania species. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
282por Clementi, Anna, Battaglia, Giorgio, Floris, Matteo, Castellino, Pietro, Ronco, Claudio, Cruz, Dinna N.“…More than 20 leishmanial species are responsible for four main clinical syndromes: cutaneous leishmaniasis; mucocutaneous leishmaniasis; visceral leishmaniasis, also known as kala-azar, and post-kala-azar dermal leishmaniasis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
283por Koster, Kira-Lee, Laws, Hans-Jürgen, Troeger, Anja, Meisel, Roland, Borkhardt, Arndt, Oommen, Prasad Thomas“…Leishmaniasis is caused by different species of the protozoa, Leishmania, and frequently found in South-Western Asia, Eastern Africa, Brazil, and Mediterranean countries. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
284por Mouri, Oussama, Benhamou, Mathilde, Leroux, Gaëlle, Chartrel, Nathalie, Devidas, Alain, Thellier, Marc, Amoura, Zahir, Costedoat-Chalumeau, Nathalie, Buffet, Pierre“…BACKGROUND: Visceral leishmaniasis (VL), i.e., infection with Leishmania sp. associated with high fever, weight loss, massive splenomegaly and markedly altered laboratory parameters, is generally fatal if untreated. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
285por Rodrigues, Igor A., Mazotto, Ana Maria, Cardoso, Verônica, Alves, Renan L., Amaral, Ana Claudia F., Silva, Jefferson Rocha de Andrade, Pinheiro, Anderson S., Vermelho, Alane B.“…Leishmaniasis is a vector-borne disease that affects several populations worldwide, against which there are no vaccines available and the chemotherapy is highly toxic. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
286“…BACKGROUND: Cutaneous leishmaniasis (CL) is an infectious disease of tropical and semitropical areas of the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
287por Yeşilova, Yavuz, Aksoy, Mustafa, Sürücü, Hacer Altun, Uluat, Ahmet, Ardic, Nurittin, Yesilova, AbdullahEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
288“…Visceral leishmaniasis (VL) is the most devastating parasitic infection worldwide causing high morbidity and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
289por Faleiro, Rebecca J., Kumar, Rajiv, Bunn, Patrick T., Singh, Neetu, Chauhan, Shashi Bhushan, Sheel, Meru, Amante, Fiona H., Montes de Oca, Marcela, Edwards, Chelsea L., Ng, Susanna S., Best, Shannon E., Haque, Ashraful, Beattie, Lynette, Hafner, Louise M., Sacks, David, Nylen, Susanne, Sundar, Shyam, Engwerda, Christian R.“…Here, we examined the potential of modulating glucocorticoid-induced TNF receptor-related protein (GITR) on T cells to improve anti-parasitic immunity in blood and spleen tissue from visceral leishmaniasis (VL) patients infected with Leishmania donovani. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
290“…Leishmaniasis is a group of diseases with varied clinical manifestations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
291por Morimoto, Ayako, Omachi, Satoko, Osada, Yasutaka, Chambers, James K., Uchida, Kazuyuki, Sanjoba, Chizu, Matsumoto, Yoshitsugu, Goto, Yasuyuki“…There are reports on up-regulated hemophagocytosis in patients with infectious diseases including typhoid fever, tuberculosis, influenza and visceral leishmaniasis (VL). However, mechanisms of infection-associated hemophagocytosis remained elusive due to a lack of appropriate animal models. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
292
-
293por Brito, Flávio Gonçalves, Langoni, Helio, Silva, Rodrigo Costa da, Rotondano, Tereza Emmanuelle de Farias, Melo, Marcia Almeida de, Paz, Giselle Souza da“…BACKGROUND: Visceral leishmaniasis (VL) is a zoonosis that affects dogs and other mammals, including humans. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
294“…Moreover, most of the knowledge involving the development of cutaneous leishmaniasis (CL) vaccines comes from the mouse model of infection with Leishmania major, which cannot be fully applied to New World Leishmaniasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
295por Tachfouti, Nabil, Najdi, Adil, Alonso, Sergi, Sicuri, Elisa, Laamrani El Idrissi, Abderahmane, Nejjari, Chakib, Picado, Albert“…BACKGROUND: Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
296por Al-Mendalawi, Mahmood DhahirEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
297
-
298
-
299
-
300por Castro, María del Mar, Gomez, Maria Adelaida, Kip, Anke E., Cossio, Alexandra, Ortiz, Eduardo, Navas, Adriana, Dorlo, Thomas P. C., Saravia, Nancy Gore“…An open-label pharmacokinetics (PK) clinical trial was conducted to comparatively assess the PK and explore the pharmacodynamics (PD) of miltefosine in children and adults with cutaneous leishmaniasis (CL) in Colombia. Sixty patients, 30 children aged 2 to 12 years and 30 adults aged 18 to 60 years, were enrolled. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto